
Dansk Pharmaceuticals India Private Limited
About Dansk Pharmaceuticals India Private Limited
Data last updated:
Dansk Pharmaceuticals India Private Limited is a private limited company based in Faridabad, Haryana, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230HR2020PTC086501. Its GSTIN is 09AAHCD7582L1ZY (Uttar Pradesh).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Ravipal Singh Rulania and Harinder Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. 2469/D Sector – 64 Faridabad, Haryana, India – 121004.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.43 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹1.1 Cr (net margin 45.2%) and EBITDA of ₹1.63 Cr (EBITDA margin 67.3%). Revenue has grown at a compounded annual rate (CAGR) of 387% over three years.
As per MCA filings, the company has satisfied charges of ₹52.46 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
Dansk Pharmaceuticals India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-03-0004012).
Company details
Recognitions & Rankings of Dansk Pharmaceuticals India
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-03-0004012
Contact details
Dansk Pharmaceuticals India Private Limited's registered office is in Faridabad, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No. 2469/D Sector – 64 Faridabad, Haryana, India – 121004
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Dansk Pharmaceuticals India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dansk Pharmaceuticals India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Dansk Pharmaceuticals India Private Limited, buy the company report.
Financials of Dansk Pharmaceuticals India Private Limited
FY 2025 filings availableDansk Pharmaceuticals India Private Limited reported revenue of ₹2.43 Cr (up 14% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 387% over three years, including 14% growth in the latest year. EBITDA rose 79% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.63 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹1.1 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 67.3% | |||
| Net Profit Margin | 45.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Dansk Pharmaceuticals India Private Limited, buy the company report.
Board of directors of Dansk Pharmaceuticals India Private Limited
Dansk Pharmaceuticals India has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravipal Singh Rulania | Director | 09 Apr 2025 | 1 Years 7 Months | Current |
| Harinder Singh | Director | 01 Feb 2021 | 5 Years 9 Months | Current |
| Sunil Kumar | Director | 02 Jun 2020 | 6 Years 5 Months | Current |
| Kuldeep Sangwan | Director | 02 Jun 2020 | 6 Years 5 Months | Current |
| Bhagat Singh Also directs: Lohagarh Organics Private Limited, Suzanna Jewels Private Limited, Lohagarh Kings Land Private Limited and 5 more | Director | 15 May 2022 | 4 Years 6 Months | Current |
Shareholding
The shareholding of Dansk Pharmaceuticals India Private Limited is on record for 2 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Dansk Pharmaceuticals India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Mar 2022 | 100553451 | Others | ₹52.46 Lakh | Satisfied |
To see the full charge records of Dansk Pharmaceuticals India Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Dansk Pharmaceuticals India Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West, Delhi | Civil suit | Filed against the company by Om Trax Packaging Solutions Limited | Disposed |
To see the full case history of Dansk Pharmaceuticals India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dansk Pharmaceuticals India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Dansk Pharmaceuticals India Private Limited has 1 active EPFO establishment as of Nov 19, 2026.
GST
Dansk Pharmaceuticals India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAHCD7582L1ZY | Uttar Pradesh | Active | 31 Jul 2020 |
To see the full GST registrations and return filing status of Dansk Pharmaceuticals India Private Limited, buy the company report.
Recent activity
Dansk Pharmaceuticals India Private Limited has 11 board changes on record since 2020: 6 appointments and 5 cessations. The latest: Renu Kumar ceased to be Director on 12 Apr 2025.
4 earlier events are in the company report.
Frequently asked questions
Dansk Pharmaceuticals India is an active private limited company based in Faridabad, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 June 2020 (6+ years old) and is registered under CIN U24230HR2020PTC086501.
Dansk Pharmaceuticals India has 5 current directors:
- Ravipal Singh Rulania - Director
- Harinder Singh - Director
- Sunil Kumar - Director
- Kuldeep Sangwan - Director
- Bhagat Singh - Director
The latest financial statements of Dansk Pharmaceuticals India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Dansk Pharmaceuticals India is 09AAHCD7582L1ZY, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Dansk Pharmaceuticals India is U24230HR2020PTC086501. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dansk Pharmaceuticals India has 1 court case on record: 1 filed against it.
Dansk Pharmaceuticals India was incorporated on 02 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Renu Kumar ceased to be Director on 12 Apr 2025. Ravipal Singh Rulania was appointed as Director on 09 Apr 2025. Gautam Gupta ceased to be Director on 08 Oct 2024. Dansk Pharmaceuticals India has 11 board changes on record in total.
Yes, Dansk Pharmaceuticals India is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Dansk Pharmaceuticals India is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-03-0004012).

